Active NPI 1487909826 Individual Practitioner Female Practitioner

Tara Lyn Bell , NP

Nurse Practitioner • Rochester, MN

✓ Accepts Medicare Assignment

Professional Overview & Biography Verified Profile Summary

Tara Bell, NP is a certified Nurse Practitioner practicing in Rochester, MN. With approximately 16 years of clinical experience since completing medical education in 2010, Tara Bell delivers high-quality medical care to the local community at 200 1ST ST SW.

Tara Bell is affiliated with Texas Digestive Disease Consultants, Pllc and accepts Medicare assignment.

Frequently performed procedures and clinical services include injection, vedolizumab, intravenous, 1 mg, injection, infliximab, excludes biosimilar, 10 mg, infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less. Full Medicare procedure pricing transparency rates and service volume details are listed on this profile.

Practice Location & Contact Primary Location

Practice Address

200 1st St Sw

Rochester, MN 559050001

Telephone 5072842511

Associated Practice Facility / Clinic

🏢 Mayo Collaborative Services, Inc Facility NPI 1093792350

Medicare Profile & Education

Medical School

Other

Graduation Year

2010

Medicare Assignment

✓ Accepts Assignment

Telehealth Flag

In-Person Only

Specialty Benchmarks & Practice Insights

Comparative analytics for Nurse Practitioner in Rochester, MN

Established Specialist (10-20 Yrs)

Practitioner Clinical Experience

16 Yrs +5.7 yrs vs City Avg

City Avg: 10.3 Yrs

State Avg: 11.7 Yrs

Regional Practice Density

955 Specialists

Practicing in Rochester, MN (2609 Statewide)

Telehealth Adoption Rate

28.2% Regional Adoption

In-Person Office Visits Only

Medicare Pricing Discount

81.3% Avg Savings

Under CMS Medicare Fee Schedule vs Standard Submitted Charges

Clinical Seniority & Experience Comparison

Dr. Bell (16 Years) 16 Yrs

Rochester Specialty Average (10.3 Years) 10.3 Yrs

Performed Procedures & Service Volume

Top Medicare Part B procedures performed by this practitioner

CMS Official Data (2024)

Reporting Year:

HCPCS Code & Description	Services	Patients	Submitted Charge	Medicare Allowed
J3380 Injection, vedolizumab, intravenous, 1 mg	24,900	23	$68.00	$21.82
J1745 Injection, infliximab, excludes biosimilar, 10 mg	6,291	22	$296.00	$31.43
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	107	37	$146.00	$48.80
96413 Infusion of chemotherapy into a vein up to 1 hour	82	26	$563.00	$98.68

HCPCS Code & Description	Services	Patients	Submitted Charge	Medicare Allowed
J3380 Injection, vedolizumab, intravenous, 1 mg	6,300	13	$68.00	$22.02
J1745 Injection, infliximab, excludes biosimilar, 10 mg	1,505	11	$296.00	$32.66
96413 Infusion of chemotherapy into a vein up to 1 hour	31	14	$563.00	$105.05
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	22	14	$146.00	$51.82

HCPCS Code & Description	Services	Patients	Submitted Charge	Medicare Allowed
J2357 Injection, omalizumab, 5 mg	690	11	$100.09	$27.56
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention	72	46	$50.00	$12.28
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	57	32	$250.00	$57.29
96415 Administration of chemotherapy into vein, each additional hour	17	13	$125.00	$24.99
96413 Infusion of chemotherapy into a vein up to 1 hour	16	14	$406.25	$117.30
99213 Established patient office or other outpatient visit, typically 15 minutes	11	11	$135.00	$77.40

HCPCS Code & Description	Services	Patients	Submitted Charge	Medicare Allowed
J0485 Injection, belatacept, 1 mg	9,675	12	$11.62	$3.24
J3111 Injection, romosozumab-aqqg, 1 mg	4,830	16	$31.29	$9.04
J0897 Injection, denosumab, 1 mg	3,480	58	$73.14	$19.98
J2357 Injection, omalizumab, 5 mg	2,085	19	$135.42	$37.44
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	1,885	12	$235.75	$43.20
J3245 Injection, tildrakizumab, 1 mg	1,700	17	$471.47	$126.06
J1602 Injection, golimumab, 1 mg, for intravenous use	1,650	11	$130.93	$17.46
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	875	12	$169.28	$51.53
J1745 Injection, infliximab, excludes biosimilar, 10 mg	820	16	$420.41	$41.62
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention	235	137	$50.00	$12.00
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	187	125	$250.00	$60.49
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	136	32	$125.00	$18.92
99213 Established patient office or other outpatient visit, typically 15 minutes	38	38	$135.00	$74.73
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg	33	15	$48.25	$5.03
96415 Administration of chemotherapy into vein, each additional hour	33	22	$125.00	$22.14
96375 Injection of additional new drug or substance into vein	26	16	$125.00	$13.45
96413 Infusion of chemotherapy into a vein up to 1 hour	25	24	$250.00	$113.04
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	24	24	$245.00	$94.26
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	15	15	$210.00	$97.14
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	14	14	$97.00	$47.47

HCPCS Code & Description	Services	Patients	Submitted Charge	Medicare Allowed
J3245 Injection, tildrakizumab, 1 mg	6,700	42	$500.59	$135.38
J2182 Injection, mepolizumab, 1 mg	6,000	11	$108.36	$27.87
J2357 Injection, omalizumab, 5 mg	5,460	15	$135.14	$37.27
J3357 Ustekinumab, for subcutaneous injection, 1 mg	3,690	38	$858.71	$181.66
J0897 Injection, denosumab, 1 mg	3,120	46	$73.14	$19.68
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention	536	154	$50.00	$12.34
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	307	23	$125.00	$18.92
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	304	78	$250.00	$61.67
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	146	124	$210.00	$93.56
96375 Injection of additional new drug or substance into vein	109	28	$125.00	$13.98
96415 Administration of chemotherapy into vein, each additional hour	92	21	$125.00	$25.18
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less	64	14	$250.00	$26.91
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg	57	20	$69.75	$6.14
96413 Infusion of chemotherapy into a vein up to 1 hour	48	22	$250.00	$117.57
J3490 Unclassified drugs	43	13	$37.65	$9.96
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	29	29	$245.00	$93.09
99202 New patient office or other outpatient visit, typically 20 minutes	15	15	$165.00	$65.75

HCPCS Code & Description	Services	Patients	Submitted Charge	Medicare Allowed
J1439 Injection, ferric carboxymaltose, 1 mg	11,250	11	$5.07	$1.07
J3357 Ustekinumab, for subcutaneous injection, 1 mg	6,480	65	$835.99	$183.86
J2357 Injection, omalizumab, 5 mg	4,830	14	$130.95	$36.37
J0897 Injection, denosumab, 1 mg	2,820	42	$71.55	$18.63
J1745 Injection, infliximab, excludes biosimilar, 10 mg	2,810	15	$420.41	$68.32
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	351	73	$250.00	$61.96
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention	319	139	$50.00	$14.41
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	227	20	$125.00	$18.72
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	139	116	$210.00	$93.12
96413 Infusion of chemotherapy into a vein up to 1 hour	129	47	$250.00	$116.63
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	107	45	$119.13	$68.03
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg	106	19	$49.70	$6.11
96375 Injection of additional new drug or substance into vein	93	24	$125.00	$13.64
96415 Administration of chemotherapy into vein, each additional hour	82	24	$125.00	$24.42
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less	53	14	$250.00	$26.02
99202 New patient office or other outpatient visit, typically 20 minutes	41	41	$165.00	$65.66
J1200 Injection, diphenhydramine hcl, up to 50 mg	35	13	$13.91	$0.69
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	29	29	$245.00	$90.34

HCPCS Code & Description	Services	Patients	Submitted Charge	Medicare Allowed
J2357 Injection, omalizumab, 5 mg	4,605	15	$127.17	$35.71
J3357 Ustekinumab, for subcutaneous injection, 1 mg	4,545	51	$499.45	$186.60
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	3,200	12	$150.66	$50.03
J1745 Injection, infliximab, excludes biosimilar, 10 mg	2,183	19	$420.22	$80.31
J0897 Injection, denosumab, 1 mg	1,440	22	$67.69	$17.33
96413 Infusion of chemotherapy into a vein up to 1 hour	340	83	$250.00	$118.14
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	322	52	$250.00	$60.85
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	287	77	$119.13	$67.03
J1335 Injection, ertapenem sodium, 500 mg	223	14	$306.54	$57.16
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	146	19	$125.00	$18.32
96415 Administration of chemotherapy into vein, each additional hour	122	42	$125.00	$25.75
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg	80	17	$46.10	$6.35
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	61	56	$210.00	$89.54
96375 Injection of additional new drug or substance into vein	48	14	$125.00	$15.06
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention	33	28	$50.00	$16.79
J1200 Injection, diphenhydramine hcl, up to 50 mg	32	12	$16.32	$0.58
99202 New patient office or other outpatient visit, typically 20 minutes	22	22	$165.00	$62.30
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	22	22	$245.00	$86.35
99213 Established patient office or other outpatient visit, typically 15 minutes	13	13	$135.00	$60.69

HCPCS Code & Description	Services	Patients	Submitted Charge	Medicare Allowed
J2323 Injection, natalizumab, 1 mg	8,400	11	$66.64	$17.46
J2357 Injection, omalizumab, 5 mg	7,247	16	$131.33	$33.01
J1745 Injection, infliximab, excludes biosimilar, 10 mg	2,770	16	$427.07	$86.71
J3357 Ustekinumab, for subcutaneous injection, 1 mg	1,485	18	$645.36	$182.29
J0897 Injection, denosumab, 1 mg	1,380	20	$65.32	$16.51
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	287	78	$250.00	$57.80
96413 Infusion of chemotherapy into a vein up to 1 hour	215	68	$250.00	$112.05
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention	194	39	$46.52	$21.39
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	162	41	$119.13	$62.24
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less	117	29	$241.45	$25.11
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	106	17	$125.00	$15.72
J1335 Injection, ertapenem sodium, 500 mg	102	11	$262.65	$49.03
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg	98	24	$37.07	$5.82
96415 Administration of chemotherapy into vein, each additional hour	97	33	$125.00	$23.12
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	73	60	$210.00	$88.86
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	43	43	$345.00	$136.53
J1200 Injection, diphenhydramine hcl, up to 50 mg	29	11	$12.61	$0.60
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	17	17	$440.00	$163.78

Medical Specialties & State Licenses

Nurse Practitioner Primary Specialty

NUCC Taxonomy Code: 363L00000X

State License MN R 208747-4

(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.

Hospital & Practice Group Affiliations

Texas Digestive Disease Consultants, Pllc

1600 Coit Rd, Plano, TX 750756173

Phone: 9727585484

Practice Associates & Co-Workers

Healthcare professionals and specialists practicing at this location or sharing practice phone/fax

40 Associated Practitioners

Dr. Emily Leasure , MD

Internal Medicine

NPI 1003005836

Doctor of Medicine (M.D.)

Nathanael Bailey

Pathology - Clinical Pathology/Laboratory Medicine

NPI 1003013814

Nicole Nipper , NP

Nurse Practitioner

NPI 1003016940

Nurse Practitioner

Brandi D'souza , NP

Nurse Practitioner

NPI 1003019696

Nurse Practitioner

Dr. Kim Schutterle , MD

Emergency Medicine

NPI 1003027087

Doctor of Medicine (M.D.)

Dr. Jodi Moore-Weiss , OD

Optometrist

NPI 1003036427

Doctor of Optometry

Career & Practice History Timeline

Chronological log of verified NPI updates, location relocations, credentials, and registry changes

6 Historical Events

✅

NPI Profile Active October 01, 2012

NPI status registered as active in NPPES database

📍

Updated Practice Location October 01, 2012

Registered at 200 1ST ST SW, ROCHESTER, MN 559050001 (Tel: 5072842511)

📍

Updated Business Mailing Address October 01, 2012

Registered at 200 1ST ST SW, ROCHESTER, MN 559050001 (Tel: 5072842511)

👤

Provider Name / Credentials Updated October 01, 2012

Recorded as TARA BELL, NP

🎓

Medical Taxonomy / Specialty Registered (Primary Specialty) October 01, 2012

Nurse Practitioner (License #R 208747-4 in MN)

🟢

Initial NPI Registration & Enumeration July 23, 2012

First registered as active Individual Practitioner in NPPES Database.

Patient & Community Reviews

Verified patient ratings, medical care experiences, and facility photos

0 Reviews

No patient reviews submitted yet for Tara Bell. Be the first to share your experience!

Only verified registered users can submit ratings, post feedback, and upload facility photos.

NPI Administrative Meta

NPI Number: 1487909826

Entity Type:

Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)

Enumeration Date: July 23, 2012

Last Update: October 01, 2012

Sole Proprietor: No

Update or Correct Profile

Mailing Address

200 1st St Sw

Rochester, MN 559050001

Phone: 5072842511

Public Domain Record This profile contains public domain information published by CMS and NPPES under the Freedom of Information Act (FOIA).

⚠️ Medical Disclaimer

This directory listing is for informational purposes only and does not constitute medical advice, diagnosis, or physician endorsement. If you are experiencing a medical emergency, please call 911 immediately.